Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Active not recruiting

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)

Outcome
Ongoing
Phase
No phase (not a drug trial)
Status
Active not recruiting
Study type
Interventional
Start
20 September 2021
Expected end
20 September 2027
Enrollment
324 participants
Sites
7
Primary outcomes
Average Fatigue Severity from the Brief Fatigue Inventory (BFI)
Sponsor type
Academic / other
Results posted
No
Last update
20 October 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The overarching long-term goal of the Integrative Medicine for Patient-reported Outcomes Values and Experience (IMPROVE) research program is to evaluate whether integrating a virtual mind-body programming, Integrative Medicine at Home (IM@Home), will improve patient perceived values, outcomes, and experiences as they undergo systemic cancer treatment such as chemotherapy, immunotherapy, radiotherapy, targeted agents, cytoreductive surgery.